Current and future pharmacotherapies of premature ejaculation.

@article{Hellstrom2006CurrentAF,
  title={Current and future pharmacotherapies of premature ejaculation.},
  author={Wayne J. G. Hellstrom},
  journal={The journal of sexual medicine},
  year={2006},
  volume={3 Suppl 4},
  pages={332-41}
}
INTRODUCTION There are currently no oral or topical agents approved by government regulation agencies for the management of premature ejaculation (PE). AIM To review pharmacologic therapies for treatment of PE. METHODS The Sexual Medicine Society of North America hosted a State of the Art Conference on Premature Ejaculation on June 24-26, 2005 in collaboration with the University of South Florida. The purpose was to have an open exchange of contemporary research and clinical information on… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Chronic administration of selective serotonin reuptake inhibitors ( SSRIs ) is associated with an increased adverse event profile encompassing dry mouth , nausea , drowsiness , and reduced libido .
Their use may also facilitate the development of other sexual dysfunctions , such as anejaculation and erectile dysfunction ( ED ) .
Their use may also facilitate the development of other sexual dysfunctions , such as anejaculation and erectile dysfunction ( ED ) .
All Topics